Biotech company Ribometrix snags $7.5 mln seed
Ribometrix Inc, a biotech company focused on developing small molecule modulators of RNA to treat disease, has raised $7.5 million in seed funding. SV Health Investors and Hatteras Venture Partners led the round with participation from AbbVie Ventures, the Dementia Discovery Fund, MP Healthcare Venture Management and Alexandria Venture Investments.
31 October 2017•1 min read
